Results 91 to 100 of about 2,896,689 (257)

Graph Pattern Matching: From Intractable to Polynomial Time [PDF]

open access: yes, 2010
Graph pattern matching is typically defined in terms of sub-graph isomorphism, which makes it an np-complete problem. Moreover, it requires bijective functions, which are often too restrictive to characterize patterns in emerging applications. We propose
Li, Jianzhong   +5 more
core  

p190A/ARHGAP35 and p190B/ARHGAP5 proteins in endometrial cancer: a novel cancer‐relevant paralog interplay

open access: yesMolecular Oncology, EarlyView.
This study identifies ARHGAP5, in addition to the frequently mutated ARHGAP35, as significantly mutated in endometrial cancer. Mutations in both genes co‐occur and are associated with their correlated downregulation. Functional CRISPR studies show that both paralogs regulate similar pathways, including actin cytoskeleton organization.
Mathilde Pinault   +12 more
wiley   +1 more source

Extracellular matrix remodeling and immune reprogramming drive residual tumor progression of liver cancer after incomplete microwave ablation

open access: yesMolecular Oncology, EarlyView.
Incomplete microwave ablation (iMWA) of liver cancer triggers a biphasic progression in residual tumors. At Day 3, the microenvironment is characterized by acute inflammatory responses and extracellular matrix (ECM) remodeling. By Day 14, a profound shift occurs toward oncogenic signal transduction and immunosuppression, marked by macrophage ...
Yu Liu   +9 more
wiley   +1 more source

A survey of two-dimensional graph layout techniques for information visualisation [PDF]

open access: yes, 2012
Many algorithms for graph layout have been devised over the last 30 years spanning both the graph drawing and information visualisation communities. This article first reviews the advances made in the field of graph drawing that have then often been ...
Vickers, Paul, Gibson, Helen, Faith, Joe
core   +1 more source

SPHINX31 acts as a SRPK1 inhibitor targeting the ATR/DNA‐PKcs/CHK1 replicative checkpoint to inhibit cell growth in non‐small cell lung cancer

open access: yesMolecular Oncology, EarlyView.
The kinase SRPK1 directly interacts with the protein TOPBP1 and regulates the pre‐mRNA splicing of WIZ thereby contributing to the activation of the ATR/CHK1 replicative checkpoint in response to replicative stress. This allows cancer cells' genomic stability and survival.
Amani Shreim   +17 more
wiley   +1 more source

A Method for Testing Graph Visualizations Using Games [PDF]

open access: yes, 2007
We describe a system that enables us to perform exploratory empirical experiments with graph visualization techniques by incorporating them into games that can be played on an internet site, the Graph Games Website (http://www.cs.kent.ac.uk/projects ...
Bovey, John D.   +3 more
core   +1 more source

Targeting the EpCAM‐AXL axis to overcome drug resistance in lung cancer

open access: yesMolecular Oncology, EarlyView.
Lung cancer cells often evade therapy by hijacking signaling pathways. We reveal that cleaved EpCAM (sEpCAM) stabilizes the oncogenic protein AXL, driving NF‐κB and STAT3‐mediated chemoresistance. This EpCAM‐AXL axis identifies a high‐risk patient subset with poor prognosis.
Alexa Guerrero‐Alba   +5 more
wiley   +1 more source

A Concise Study of Some Superhypergraph classes [PDF]

open access: yesNeutrosophic Sets and Systems
In graph theory, the hypergraph extends the traditional graph structure by allowing edges to connect multiple vertices, and this concept is further broadened by the superhypergraph.
Florentin Smarandache, Takaaki Fujita
doaj   +1 more source

Singed Total Domatic Number of a Graph [PDF]

open access: yes, 2010
The maximum number of functions in a signed total dominating family on G is the signed total domatic number of G. In this paper, some properties related signed total domatic number and signed total domination number of a graph are studied and found the ...
Shailaja S. Shirkol   +2 more
core   +1 more source

Characterization of therapeutic antibodies targeting lymphatic and vascular resistance factor for the treatment of hypervascularized and highly metastatic cancers

open access: yesMolecular Oncology, EarlyView.
LVRF (lymphatic and vascular resistance factor) is a VEGFA splice variant upregulated in response to anti‐angiogenic therapy that fosters tumor adaptation through enhanced vascularization, lymphangiogenesis, and metastatic dissemination. Targeting LVRF with fully human neutralizing antibodies disrupts these processes and limits resistant tumor growth ...
Marion David   +12 more
wiley   +1 more source

Home - About - Disclaimer - Privacy